On February 16, 2021, Freeline Therapeutics Holdings plc announced the resignation of Brian M. Silver from his position as Chief Financial Officer, effective April 30, 2021, in order to pursue a new opportunity. Mr. Silver's resignation is not due to any disagreement with the company or the Board of Directors, nor to any matter relating to the company's operations, financial statements, internal controls, auditors, policies or practices.